May 18, 2020 / 10:20 PM / 8 days ago

BRIEF-Dynavax Says Intend To Provide Update On Early-Stage Collaborations Regarding Potential Development Of COVID-19 Vaccine

May 18 (Reuters) - Dynavax Technologies Corp:

* DYNAVAX TECHNOLOGIES - ON MAY 19, INTENDS TO PROVIDE UPDATE ON EARLY-STAGE COLLABORATIONS REGARDING POTENTIAL DEVELOPMENT OF A VACCINE FOR COVID-19

* DYNAVAX TECHNOLOGIES - EXPECTS ONE OR MORE OF COLLABORATION PARTNERS TO COMMENCE A PHASE 1 CLINICAL TRIAL OF POTENTIAL COVID-19 VACCINE AS SOON AS JULY

* DYNAVAX - IF CO IS UNABLE TO GET OR ENFORCE PROPRIETARY RIGHTS IN CPG-1018, IT MAY BE UNABLE TO REALIZE COMMERCIAL BENEFIT FROM COVID-19 VACCINE DEVELOPMENT Source text: (bit.ly/2TgiC18) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below